Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radical Anti-Markovnikov Addition to Alkenes: Overview01:25

Radical Anti-Markovnikov Addition to Alkenes: Overview

The addition of hydrogen bromide to alkenes in the presence of hydroperoxides or peroxides proceeds via an anti-Markovnikov pathway and yields alkyl bromides.
Mass Spectrometry: Complex Analysis01:21

Mass Spectrometry: Complex Analysis

Mass spectrometry is an important technique for the identification of pure compounds. However, it has some limitations for the analysis of complex mixtures, often due to excessive fragmentation making the spectrum too complicated to decipher. Mass spectrometry can be combined with suitable separation methods in sequence, forming hyphenated methods, which are useful in the analysis of complex mixtures.
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Radical Anti-Markovnikov Addition to Alkenes: Mechanism01:17

Radical Anti-Markovnikov Addition to Alkenes: Mechanism

The reaction of hydrogen bromide with alkenes in the presence of hydroperoxides or peroxides proceeds via anti-Markovnikov addition. The radical chain reaction comprises initiation, propagation, and termination steps.
The mechanism starts with chain initiation, which involves two steps. In the first chain initiation step, a weak peroxide bond is homolytically cleaved upon mild heating to form two alkoxy radicals. In the second initiation step, a hydrogen atom is abstracted by the alkoxy radical...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Algebraic Expressions01:26

Algebraic Expressions

Algebraic expressions are essential in mathematics. They represent relationships through variables, constants, and operations. These expressions help describe patterns and solve problems in various mathematical fields. Understanding their components, classifications, and operations allows for efficient simplification and manipulation.Each algebraic expression consists of individual parts, including numbers and symbols, that work together to form meaningful mathematical statements. The numerical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

JCO oncology practice·2025
Same author

Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Blood·2025
Same author

Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study.

Cancer chemotherapy and pharmacology·2023
Same author

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.

Leukemia·2023
Same author

CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia.

Frontiers in oncology·2023
Same author

Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.

Blood·2023

Related Experiment Video

Updated: May 24, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Unveiling the complexity of CK+ AML.

Bruno C Medeiros1

  • 1Stanford University School of Medicine.

Blood
|March 3, 2012
PubMed
Summary

Cytogenetic abnormalities, or chromosomal alterations, are common in acute myeloid leukemia (AML). These changes significantly impact patient chemotherapy response and overall survival outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Cytogenetics

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • Cytogenetic abnormalities are detected in over 50% of AML patients.
  • These chromosomal alterations are recognized as crucial prognostic indicators.

Discussion:

  • The presence and type of chromosomal alterations in AML correlate with treatment efficacy.
  • Understanding these genetic changes is vital for predicting patient outcomes.
  • Cytogenetic analysis aids in risk stratification and personalized treatment strategies.

Key Insights:

  • Chromosomal abnormalities in AML are not merely incidental findings but functional drivers.
  • These alterations directly influence sensitivity or resistance to chemotherapy regimens.

Related Experiment Videos

Last Updated: May 24, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

  • Survival rates are demonstrably linked to specific cytogenetic profiles.

    • Outlook:

    • Further research into targeted therapies based on specific AML cytogenetics is warranted.
    • Integration of advanced genomic techniques will refine prognostic accuracy.
    • Personalized medicine approaches in AML will increasingly rely on detailed cytogenetic characterization.